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Lead is a ubiquitous environmental contami-
nant whose toxicity, including reproductive
and developmental effects in humans, is well
known (Bellinger 1994; National Research
Council 2000). Lead has been used as both a
spermicide and abortifacient and has even been
implicated in the fall of the ancient Roman
Empire (Nriagu 1983). Although environmen-
tal and blood lead levels have declined over
time (Pirkle et al. 1994), concern remains
about the potential adverse impact of lead
exposure on subtle aspects of child growth and
development, including reproductive function.
A recent study (Lanphear et al. 2000) reported
cognitive deficits associated with blood lead
concentration < 10 µg/dL in children and ado-
lescents. Puberty—the onset of fecundity or
the biologic capacity for reproduction—repre-
sents an important yet understudied health
outcome that may be altered at relatively low
levels of lead exposure.
Subtle lead-related effects on sexual matu-
ration have been reported in animal studies.
For example, laboratory animals exposed to
lead prenatally and/or as juveniles were
reported to have experienced delayed puberty
or sexual maturation (Der et al. 1974;
Kimmel et al. 1980; Ronis et al. 1998b). To
address these ﬁndings, we assessed measures of
puberty in U.S. girls in relation to blood lead
levels to determine if there was any evidence
in humans that sexual maturation may be
adversely affected by current environmental
lead levels.
Methods
Data. We used data from the Third National
Health and Nutrition Examination Survey
(NHANES III), 1988–1994, to assess the
relation between blood lead levels and puber-
tal milestones in U.S. girls. Briefly, the
NHANES III is a cross-sectional survey that
used a stratified multistage probability sam-
pling design to obtain nationally representa-
tive information on the health and nutrition
of the U.S. population using interviews and
physical examinations (n = 39,695). The
NHANES III represents the noninstitutional-
ized civilian U.S. population 2 months or
older who reside in the 50 states and the
District of Columbia. Detailed information
on the sample design and conduct of the
NHANES III is available elsewhere (National
Center for Health Statistics 1994).
Study sample. There were 7,050 girls
1–16 years old who participated in the youth
sample of NHANES III. Only girls 8 years or
older were eligible for Tanner staging of
pubic hair and breast development (National
Center for Health Statistics 1998). Our study
sample is restricted to the 1,706 girls 8–16
years old who could provide information on
blood lead, Tanner staging of pubic hair and
breast development, and other variables of
interest. Menarche was ascertained in the
NHANES III for girls 10 years or older. As
such, among the 1,706 girls, menarche data
were available for 1,235 girls. We refer to
these two samples as study samples 1 and 2,
respectively.
Markers of sexual maturation. Physicians
assessed pubic hair and breast development
using Tanner staging (Tanner 1986) as
described in the Physician Examiners Training
Manual (Centers for Disease Control and
Prevention 1996), which required a chaperone
to be in the room. Tanner stage 2 pubic hair
was defined in the study protocol as “sparse
growth of long, slightly pigmented downy
hair, straight or only slightly curled, appearing
chieﬂy along the labia”; stage 2 breast develop-
ment was defined as the breast bud stage or
the “elevation of breast and papilla as small
mound . . . widening and elevation of the are-
ola with pigmentation.” For study purposes,
we were interested in whether girls had
reached stage 2 or more for these two puberty
markers. Refusal rates for the Tanner staging
varied by girl’s age, with the lowest rates
encountered for girls 8 years old and the high-
est rates for girls 15 years old. Specifically,
refusal rates ranged from 8 to 15% for pubic
hair staging and from 6 to 13% for breast
staging. Girls 10–16 years old were asked
about whether they had had a period/men-
strual cycle, and the attainment of menarche
was defined in this study based on the self-
reported data. Among girls 10–16 years old
(n = 1,973) who participated in NHANES
III, 1,580 (80.1%) had information on
attainment of menarche.
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Using data from the Third National Health and Nutrition Examination Survey, we assessed
measures of puberty in U.S. girls in relation to blood lead levels to determine whether sexual mat-
uration may be affected by current environmental lead exposure. The study sample included 1,706
girls 8–16 years old with pubic hair and breast development information; 1,235 girls 10–16 years
old supplied information on menarche. Blood lead concentrations (range = 0.7–21.7 µg/dL) were
categorized into three levels: 0.7–2.0, 2.1–4.9, and 5.0–21.7 µg/dL. Sexual maturation markers
included self-reported attainment of menarche and physician determined Tanner stage 2 pubic
hair and breast development. Girls who had not reached menarche or stage 2 pubic hair had
higher blood lead levels than did girls who had. For example, among girls in the three levels of
blood lead described above, the unweighted percentages of 10-year-olds who had attained Tanner
stage 2 pubic hair were 60.0, 51.2, and 44.4%, respectively, and for girls 12 years old who
reported reaching menarche, the values were 68.0, 44.3, and 38.5%, respectively. The negative
relation of blood lead levels with attainment of menarche or stage 2 pubic hair remained signiﬁ-
cant in logistic regression even after adjustment for race/ethnicity, age, family size, residence in
metropolitan area, poverty income ratio, and body mass index. In conclusion, higher blood lead
levels were significantly associated with delayed attainment of menarche and pubic hair among
U.S. girls, but not with breast development. Key words: fecundity, lead, menarche, puberty, sexual
maturation. Environ Health Perspect 111:737–741 (2003). doi:10.1289/ehp.6008 available via
http://dx.doi.org/ [Online 4 February 2003]
Children’s Health | ArticleLaboratory lead measurement. A blood
specimen was obtained from children during
the physical examination via venipuncture.
Blood lead levels were measured by the labora-
tory at the National Center for Environmental
Health, Centers for Disease Control and
Prevention (CDC), using a graphite furnace
atomic absorption spectrophotometer based
on the methodology of Miller et al. (1987). In
the study sample, blood lead levels ranged
from 0.7 to 21.7 µg/dL and were categorized
into three levels for the analysis of level speciﬁc
effect: 0.7–2.0 µg/dL, 2.1–4.9 µg/dL, and
5.0–21.7 µg/dL. Only 26 girls in the sample
had blood lead levels greater than 10 µg/dL.
Detailed information on blood lead levels for
the entire NHANES III sample was reported
elsewhere (CDC 1997; Pirkle et al. 1994).
Operational deﬁnitions. Blood lead level is
our study exposure, and sexual maturation as
measured by Tanner stage 2 for pubic hair and
breast development, and attainment of me-
narche are our study outcomes. Other study
covariates considered to be potential con-
founders for the analysis included race/ethnic-
ity, age, family size, residence, poverty income
ratio, and body mass index (BMI). These vari-
ables are based on the operational deﬁnitions
set forth in NHANES III. Race/ethnicity
referred to the following four categories as
reported by the primary respondent in the
screening and family interview portion of the
survey: non-Hispanic white, non-Hispanic
African American, Mexican American, and
other (i.e., Hispanics not of Mexican origin or
non-Hispanics from racial groups other than
white or African American). Age referred to
chronologic age (in completed months) at the
time of the NHANES III exam and was con-
verted (divided by 12) to years for analysis.
Family size referred to the number of family
members who were living in the household,
and residency referred to the rural/urban code
based on U.S. Department of Agriculture
codes that described metropolitan and non-
metropolitan counties by degree of urbaniza-
tion and nearness to metropolitan areas
(National Center for Health Statistics 1998).
These codes were later recoded into two cate-
gories in the NHANES III data set to ensure
conﬁdentiality of data: 1, metro (i.e., central
or fringe counties of metropolitan areas of ≥ 1
million population) or 2, nonmetro (all other
areas). The poverty income ratio is the ratio of
the reported family incomes divided by the
poverty threshold, which was produced annu-
ally by the Census Bureau and adjusted for
changes caused by inﬂation. The variable was
categorized into < 1, 1–2, > 2, and a missing
category was also created for analysis. Weight
and height were measured in NHANES III,
and BMI (kilograms per square meter) was
computed by dividing weight (in kilograms)
by height (in meters) squared.
Statistical analysis. The unweighted and
weighted means and proportions were calcu-
lated to describe the study population/sample
with respect to the covariates of interest. For
each age, the unweighted percentages of girls
with pubic hair, breast development, and
attainment of menarche were computed for
each category of blood lead. The Cochran-
Mantel Haenszel chi-square test controlling
for age with the application of weights was
used to test percentage differences by category
of blood lead. Unweighted age-speciﬁc mean
blood lead levels were computed for girls who
had and had not attained each marker of sex-
ual maturation. Girls who attained a puberty
marker were compared with those who did
not with respect to the means in the natural
logarithm–transformed values of blood lead
after controlling for age using analysis of vari-
ance (ANOVA) with weighting. The sample
size in each age is small, so age-specific
weighted statistics were not computed. The
attainment of puberty across the blood lead
groups for all ages combined was also ana-
lyzed by logistic regression with weighting
and the adjustment for race/ethnicity, age,
family size, residence, poverty income ratio,
and BMI. Specifically, the presence of a
pubertal characteristic (pubic hair, breast
development, or attainment of menarche)
served as a dependent variable, whereas in
addition to blood lead, race/ethnicity, age,
family size, residence, poverty income ratio,
and BMI were fit into logistic regression
models to test whether their associations with
the dependent variable were independent. To
take into consideration the sampling strategy
such as stratiﬁcation and clustering employed
in the NHANES III, all weighted analyses
described above were performed using
SUDAAN statistical software (SUDAAN
1995) using the weights established for the
NHANES III examination sample. The SAS
software package was used for the unweighted
analyses (SAS 1992).
Results
Study sample 1 (n = 1,706) was composed of
girls who ranged in age from 8 to 16 years
(mean 12.2 ± 2.6 years). Reﬂecting the study
design of NHANES III, the study sample
included a nearly equal percentage of non-
Hispanic African-American and Mexican-
American girls (Table 1). A comparable
percentage of girls resided in metropolitan and
nonmetropolitan areas in both samples.
Approximately 37% of girls lived in families
with income levels below the poverty line.
Blood lead concentration ranged from 0.7 to
21.7 µg/dL, with a mean (± SD) of 2.5 ± 2.2
µg/dL. Weighted descriptive statistics from
samples 1 and 2 were provided for national
estimates of the variables of interest.
The unweighted percentages of girls hav-
ing attained menarche or Tanner stage 2 or
higher for pubic hair and breast development
are presented in Table 2. In general, a nega-
tive relation is observed between the percent-
age of girls having achieved each pubertal
milestone and blood lead levels. This pattern
is especially noticeable for younger girls. The
Cochran-Mantel Haenszel chi-square test,
after controlling for age and with weighting,
indicated significant differences across lead
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Table 1. Characteristics of the study samples: NHANES III, 1988–1994.
Sample 1 (girls 8–16 years old) Sample 2 (girls 10–16 years old)
Characteristic Unweighted Weighted Unweighted Weighted
Race/ethnicity (%)
Non-Hispanic white 25.6 65.0 25.3 64.5
Non-Hispanic African American 34.8 16.2 34.3 16.0
Mexican American 35.1 8.8 35.6 9.5
Other 4.6 10.0 4.9 10.0
Age in years (mean ± SD) 12.2 ± 2.6 12.4 13.3 ± 2.0 13.5
Family size (%)
1–2 17.2 18.2 17.2 17.8
3–6 66.3 70.3 66.9 72.6
≥ 7 16.5 115 15.9 9.6
Residency (%)
Nonmetropolitan 53.4 54.7 53.7 55.4
Metropolitan 46.6 45.3 46.3 44.6
Poverty income ratio (%)
Unknown 7.3 4.1 7.0 4.2
< 1 36.8 23.6 35.3 20.4
1–2 25.3 23.4 26.2 23.5
> 2 30.7 48.9 31.5 51.9
Blood lead [µg/dL (%)]
0–2.0 54.3 66.9 60.2 71.8
2.1–4.9 35.2 27.2 32.9 24.1
5.0–21.7 10.4 5.9 7.0 4.1
BMI (mean ± SD) 20.5 ± 4.7 20.2 21.4 ± 4.7 21.0
Sample 1 (n = 1,706) includes girls with Tanner staging and blood lead information; sample 2 (n = 1,235) contains a sub-
set of girls from sample 1 ≥ 10 years old with menarche information. Weighted statistics are calculated with the applica-
tion of weights established for the NHANES III exam sample.levels with respect to the percentage of girls
who attained stage 2 pubic hair. The relation
of blood lead levels with attainment of
menarche had marginal significance in the
weighted analysis. No significant differences
were observed for breast development across
the lead levels.
The unweighted mean blood lead levels
for each age are presented in Table 3. As the
data reﬂect, mean levels of blood lead in gen-
eral tended to be higher for girls who did not
reach puberty than for girls who did. After
controlling for age using two-way ANOVA, a
signiﬁcant difference in mean blood lead lev-
els was found for girls who reached stage 2
pubic hair compared with girls who did not.
With respect to menarche, the weighted
ANOVA shows a marginally significant dif-
ference in the mean blood lead levels. The
difference in mean blood lead levels by breast
development status was not signiﬁcant.
Results from the logistic regression analysis
are shown in Table 4. After adjustment for
age, race/ethnicity, poverty income index, resi-
dence, family size, and BMI and after taking
the NHANES III design features of stratiﬁca-
tion and cluster into account, using the
weights and SUDAAN software, blood lead
levels (both as a categorical and continuous
variable) were signiﬁcantly associated with the
attainment of pubic hair and menarche. No
signiﬁcant association was observed for blood
lead levels and breast development in this
multivariate analyses.
Discussion
Blood lead levels that are considered “accept-
able” have been changed continuously over the
past three decades as new research underscores
the human health hazards associated with envi-
ronmental lead exposure. Currently, the CDC
has deﬁned elevated blood lead concentrations
as blood lead levels > 10 µg/dL (CDC 1991).
However, possible hazards at blood lead levels
< 10 µg/dL still remain a concern (Landrigan
2000). This study found a signiﬁcant negative
association between blood lead concentrations
even at relatively low levels and physical mark-
ers of sexual maturation in U.S. girls who par-
ticipated in the NHANES III survey. This
ﬁnding suggests that despite declining blood
lead levels in the United States, current levels
may still pose concerns for the growth and
development of girls as measured by the three
pubertal milestones considered in this study.
The potentially toxic effect of lead expo-
sure on sexual maturation in humans is biolog-
ically plausible. Studies of lead workers
(McGregor and Mason 1990; Rodamilans et
al. 1988) have found chronic occupational lead
exposure to be associated with a decrease in
serum testosterone levels and/or alterations in
circulating gonadotrophin levels. Such results
suggest that lead has a direct effect on the
testes, followed by disturbances in hypothala-
mic or pituitary function. One study reported
reduced serum levels of follicle-stimulating
hormone and luteinizing hormone in children
11–13 years old with relatively low blood lead
levels (Vivoli et al. 1993), suggesting that the
reproductive system may be more sensitive to
lead toxicity during pubertal development.
Experimental animal studies (Ronis et al.
1998a, 1998b, 1998c; Sokol et al. 2002) also
revealed some endocrine toxicity of lead expo-
sure during development. For example, rats
exposed experimentally to dietary lead had sig-
niﬁcantly lower plasma steroids (testosterone in
male rats and 17β-estradiol in female rats) dur-
ing puberty (Ronis et al. 1998a). Such an effect
seems to be caused by the continuous exposure
of rats up to the onset of puberty rather than
by perinatal exposure through “endocrine
imprinting” (Ronis et al. 1998b).
The signiﬁcant relation between blood lead
and physical markers of sexual maturation
observed in this study is consistent with animal
studies that demonstrate an effect of delayed
onset of sexual maturation after lead exposure.
What is surprising yet intriguing is that this
ﬁnding, although preliminary in nature, may
suggest an effect of blood lead at levels lower
than those of concern currently established by
the CDC. Therefore, these ﬁndings underscore
the importance of prospective inquiry for
assessing the health effects associated with low
lead exposure by focusing on sensitive markers
of human development such as puberty.
Our findings are consistent with many
recent studies reporting a declining age at
puberty and declining blood lead concentra-
tions for more recently born cohorts of chil-
dren. Specifically, several authors, including
those reporting for boys in the NHANES III,
have reported earlier ages at puberty for
recent birth cohorts (Fredriks et al. 2000;
Karpati et al. 2002), whereas others have not
found much difference over time (Whincup
et al. 2001). Complicating interpretation of
these equivocal temporal trends is the obser-
vation that puberty appears to vary by
race/ethnicity but only in some countries such
as the United States (de Muinck et al. 2001;
Herman-Giddens et al. 1997; Wu et al.
2002). Possible etiologic factors cited for the
temporal pattern of declining age at puberty
include both nutritional (body size) and envi-
ronmental factors that either act indepen-
dently or interactively with genes (Bray 1997;
Treloar and Martin 1990).
The effect of the observed delays in
puberty on children’s adult health status and
fecundity is uncertain at this time. In the
study by Kimmel et al. (1980), lead-exposed
female rats that demonstrated delayed sexual
maturation were no different from unexposed
control animals with respect to the ability to
conceive and carry a normal litter to term.
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Table 2. Unweighted percentage of girls at Tanner stage 2 for pubic hair and breast development and
attainment of menarche, by age and blood lead level: NHANES III, 1988–1994.
0.7–2.0 µg/dL 2.1–4.9 µg/dL 5.0–21.7 µg/dL
Age (years) No. Percent No. Percent No. Percent p-Value
Pubic hair
87 5 18.7 70 15.7 43 7.0
98 8 36.4 102 36.3 41 19.5
10 90 60.0 82 51.2 36 44.4 0.022
11 94 85.1 101 74.3 25 80.0
12 108 97.2 74 96.0 14 85.7
13 112 98.2 56 100.0 7 100.0
14 111 99.1 48 100.0 6 100.0
15 125 100.0 27 100.0 4 100.0
16 123 100.0 42 100.0 2 100.0
Breast development
87 5 26.7 70 22.9 43 11.6
98 8 36.4 102 35.3 41 34.2
10 90 61.1 82 72.0 36 61.1 0.520
11 94 90.4 101 87.1 25 84.0
12 108 98.2 74 96.0 14 100.0
13 112 99.1 56 98.2 7 100.0
14 111 99.1 48 100.0 6 100.0
15 125 100.0 27 100.0 4 100.0
16 123 100.0 42 100.0 2 100.0
Attainment of menarche
10 85 5.9 74 2.7 33 0.0
11 90 30.0 99 16.2 22 9.1
12 103 68.0 70 44.3 13 38.5 0.091
13 110 87.3 53 79.3 6 50.0
14 110 97.3 46 87.0 6 83.3
15 123 100.0 26 100.0 5 100.0
16 122 99.2 38 100.0 2 100.0
p-Values are from Cochran-Mantel Haenszel chi-square test of the percentage differences across blood lead levels
controlling for age and after weighting and adjusting for NHANES III complex sampling using SUDAAN software.Extreme delays in the onset of puberty (> 18
years) in girls have been reported to be a risk
factor for infertility (Komura et al. 1992), and
more modest pubertal delays (13 years or
older) have been associated with other gyne-
cologic conditions such as endometriosis,
which may be in the pathway for female
infertility (Berube et al. 1998). On the other
hand, early age at menarche increases the
number of ovulatory cycles a woman experi-
ences and has been reported to increase the
risk for breast and endometrial cancer (Garlan
et al. 1998; McPherson et al. 1996). Hence,
alterations in puberty may have life-long
implications for human health and disease.
The cross-sectional design used in the
NHANES III does not allow us to assess the
temporal relation between blood lead and
puberty. Therefore, we have considered other
explanations for the observed relation between
higher blood lead levels and the delay in the
pubertal milestones. First, lower blood lead
levels among girls who attained sexual matura-
tion may be the consequence rather than
antecedent of the pubertal development.
Rapid body growth along with sexual matura-
tion is the hallmark of puberty. The fast bone
formation during pubertal development
induces more rapid deposition of calcium,
along with lead, from the blood into the bone,
and may cause redistribution of lead in the
body—albeit growing bone is turning over
rapidly and bone lead is continuously returned
to the circulation. A second explanation may
be that menstruation is an important pathway
for elimination of lead albeit modest in the
absence of pathologic menstrual bleeding,
which is unlikely in most young girls. If the
explanations were true, menstruating girls
would be expected to have lower lead levels
than nonmenstruating girls. However, the
kinetics of lead in relation to puberty mile-
stones other than age is largely unstudied, and
empirical data to support these explanations
are currently lacking (O’Flaherty 1995; U.S.
EPA 1994). Therefore, the results of this study
underscore the need for research focusing on
lead mobilization in relation to puberty mile-
stones and a greater appreciation for the path-
ways of exposures for older children. Finally,
we did not model dietary and nutritional fac-
tors, which may affect blood lead levels, nor
did we consider concomitant environmental
exposures (Lanphear et al. 1996; Six and
Goyer 1972; Watson et al. 1980). The extent
to which residual confounding explains our
ﬁndings remains to be established.
In summary, we found a signiﬁcant nega-
tive association between blood lead at rela-
tively low levels and markers of sexual
maturation suggesting that such exposure may
delay pubertal development in girls. Judicious
interpretation of this ﬁnding is needed given
the cross-sectional study sample and limited
attention to other nutritional or genetic factors
that may impact the ﬁndings. These ﬁndings
underscore the importance of considering sen-
sitive markers of human fecundity such as
puberty in relation to environmental lead
exposures.
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Table 3. Unweighted mean blood lead levels (µg/dL) by age and presence/absence of Tanner stage 2
pubertal measure and menarche: NHANES III, 1988–1994.
Absence of pubertal measure Presence of pubertal measure
Age (years) No. Mean ± SD No. Mean ± SD p-Value
Pubic hair
8 160 3.5 ± 2.6 28 2.4 ± 1.4
9 154 3.5 ± 2.6 77 3.1 ± 2.9
10 96 3.7 ± 3.6 112 2.8 ± 2.1 0.013
11 45 3.2 ± 2.7 175 2.8 ± 2.1
12 8 4.1 ± 4.7 188 2.2 ± 1.7
13 2 1.3 ± 0.8 173 2.0 ± 1.5
14 1 0.7 164 1.9 ± 1.5
15 156 1.5 ± 1.2
16 167 1.6 ± 1.0
Breast development
8 147 3.6 ± 2.6 41 2.6 ± 2.1
9 149 3.4 ± 2.8 82 3.1 ± 2.6
10 72 3.4 ± 3.8 136 3.1 ± 2.4 0.552
11 26 3.4 ± 2.6 194 2.8 ± 2.2
12 5 2.0 ± 1.3 191 2.3 ± 1.9
13 2 1.4 ± 1.0 173 2.0 ± 1.5
14 1 0.7 164 1.9 ± 1.5
15 156 1.5 ± 1.2
16 167 1.6 ± 1.0
Attainment of menarche
10 185 3.3 ± 3.0 7 1.3 ± 0.7
11 166 3.0 ± 2.3 45 2.1 ± 1.3
12 80 2.8 ± 2.5 106 2.0 ± 1.3 0.053
13 28 2.8 ± 2.4 141 1.8 ± 1.2
14 10 2.5 ± 1.8 152 1.8 ± 1.5
15 1 0.7 153 1.5 ± 1.2
16 161 1.6 ± 1.0
p-Values are for the mean difference in blood lead (natural log transformed) between presence and absence of a puberty
milestone after controlling for age using ANOVA with application of weights and the adjustment for NHANES III complex
sampling using SUDAAN software.
Table 4. Likelihooda of having attained pubertal markers by blood lead levels: NHANES III, 1988–1994.
Pubic hair Breast development Attainment of menarche
Blood lead (µg/dL) OR 95% CI OR 95% CI OR 95% CI
0.7–2.0 1.00 Reference 1.00 Reference 1.00 Reference
2.1–4.9 0.48 0.25–0.92 1.51 0.90–2.53 0.42 0.18–0.97
5.0–21.7 0.27 0.08–0.93 1.20 0.51–2.85 0.19 0.08–0.43
Log transformedb 0.54 0.32–0.91 1.20 0.76–1.92 0.52 0.28–0.97
Abbreviations: 95% CI, 95% conﬁdence interval; OR, odds ratio.
aLogistic regression with adjustment for age, race/ethnicity, poverty income ratio, metro residence, family size, and BMI
using SUDAAN software and weights established for the NHANES III exam sample. bNatural log transformed, treated as a
continuous variable. The categorical and continuous variables of blood lead were analyzed in separate models.Kimmel CA, Grant LD, Sloan CS, Gladen B. 1980. Chronic low-
level lead toxicity in the rat. Toxicol Appl Pharmacol
56:28–41.
Komura H, Miyake A, Chen CF, Tanizawa O, Yoshikawa H. 1992.
Relationship of age at menarche and subsequent fertility.
Eur J Obset Gynecol Reprod Biol 44(3):201–203.
Landrigan PJ. 2000. Pediatric lead poisoning: is there a thresh-
old? Public Health Rep 115:530–531.
Lanphear BP, Dietrich K, Auinger P, Cox C. 2000. Cognitive
deficits associated with blood lead concentration < 10
microg/dL in US children and adolescents. Public Health
Rep 115(6):521–529.
Lanphear BP, Weitzman M, Eberly S. 1996. Racial differences
in urban children’s environmental exposures to lead. Am J
Public Health 86:1460–1463.
McGregor AJ, Mason MJ. 1990. Chronic occupational lead
exposure and testicular endocrine function. Hum Exp
Toxicol 9:371–376.
McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR.
1996. Reproductive factors and risk of endometrial cancer.
The Iowa Women’s Health Study. Am J Epidemiol
143(12):1195–1202.
Miller DT, Paschal DC, Gunter EW, Stoud PE, D’Angelo J. 1987.
Determination of blood lead with electrothermal atomic
absorption using a L’vov platform and matrix modifier.
Analyst 112:1701.
National Center for Health Statistics. 1994. Plan and operation
of the Third National Health and Nutrition Examination
Survey, 1988–1994. Vital Health Stat 1(32).
———. 1998. NHANES III Household Youth Data File
Documentation. National Health and Nutrition Examination
Survey III, 1988–1994. (CD-ROM Series 11). Hyattsville,
MD:Centers for Disease Control and Prevention.
National Research Council. 2000. Scientific Frontiers in
Developmental Toxicology and Risk Assessment.
Washington, DC:National Academy Press.
Nriagu JO. 1983. Saturine gout among Roman aristocrats: did
lead poisoning contribute to the fall of the Empire? N Engl
J Med 308:660–663.
O’Flaherty EJ. 1995. Physiologically based models for bone-
seeking elements. V. Lead absorption and disposition in
childhood. Toxicol Appl Pharmacol 131:297–308.
Pirkle JL, Brodie DJ, Gunter EW, et al. 1994. The decline in
blood lead levels in the United States: the National Health
and Nutrition Examination Surveys (NHANES). JAMA
272(4):284–291.
Rodamilans M, Osaba MJM, To-Figueras J, Fillat FR, Marques
JM, Perez P, Corbella J. 1988. Lead toxicity on endocrine
testicular function in an occupational exposed population.
Hum Toxicol 7:125–128.
Ronis MJJ, Badger TM, Shema SJ, Roberson PK. 1998a.
Endocrine mechanisms underlying the growth effects of
developmental lead exposure in the rat. J Toxicol Environ
Health 54:101–120.
Ronis MJJ, Badger TM, Shema SJ, Roberson PK. Sjaikh F.
1998b. Effects on pubertal growth in rats exposed to lead
perinatally or continuously through development. J Toxicol
Environ Health 53:327–341.
Ronis MJJ, Gandy J, Badger T. 1998c. Endocrine mechanisms
underlying reproductive toxicity in the developing rat chron-
ically exposed to dietary lead. J Toxicol Environ Health
54:77–99.
SAS. 1992. SAS/STAT User’s Guide. Version 6, 4th ed. Cary,
NC:SAS Institute, Inc.
Six KM, Goyer RA. 1972. The influence of iron deficiency on
tissue content and toxicity of ingested lead in the rat.
J Lab Clin Med 79:128–136.
Sokol RZ, Wang S, Wan YY, Stanczyk FZ, Gentzscheir E, Chapin
REl. 2002. Long-term, low-dose lead exposure alters the
gonadotropin-releasing hormone system in the male rat.
Environ Health Perspect 110:871–874.
SUDAAN. 1995. User’s Manual. Release 6.40. Chapel Hill,
NC:Research Triangle Institute.
Tanner JM. 1986. Normal growth and techniques of growth
assessment. Clin Endocrinol Metab 15:411–451.
Treloar SA, Martin NG. 1990. Age at menarche as a fitness
trait: nonadditive genetic variance detected in a large twin
sample. Am J Hum Genet 47:137–148.
U.S. EPA. 1994. Guidance Manual for the Integrated Exposure
Uptake Model for Lead in Children. National Technical
Information Service. PB 93-963510. Washington, DC:U.S.
Environmental Protection Agency.
Vivoli G, Fantuzzi G, Bergomi M, Tonelli E, Gatto MR, Zanetti F,
et al. 1993. Relationship between low lead exposure and
somatic growth in adolescents. J Expo Anal Environ
Epidemiol 3(suppl 3):201–209.
Watson WS, Hume R, Moore MR. 1980. Oral absorption of lead
and iron. Lancet 2:236–237.
Whincup PH, Gilg JA, Odoki K, Taylor SJC, Cook DG. 2001. Age
of menarche in contemporary British teenagers: survey of
girls born between 1982 and 1986. Br Med J 322:1095–1096.
Wu T, Mendola P, Buck GM. 2002. Ethnic differences in the
presence of secondary sex characteristics and menarche
among U.S. girls: the Third National Health and Nutrition
Examination Survey, 1988–94. Pediatrics 110(4):752–757.
Children’s Health | Blood lead levels and sexual maturation in girls
Environmental Health Perspectives • VOLUME 111 | NUMBER 5 | May 2003 741